Methods to increase functional capacity and quality of life in bronchietasis patients with nontuberculous mycobacteria
WO2020198309A1
Gas delivery system
US2020237856A1
Method of treating patients with hepatorenal syndrome type 1
WO2020117836A1
Gas sensor module
US2020046798A1
Method of treating patients with hepatorenal syndrome type 1
CN111107742A
Method for improving organ viability
US2018256523A1
Reduced dose intravenous acetaminophen
AU2017202586A1
System and method of administering a pharmaceutical gas to a patient
KR20190015706A
Apparatus and method for detecting liquid levels in transparent or partially transparent containers
AU2017260617A1
Apparatus and method for humidity conditioning sample gas of a patient breathing circuit affiliated with a ventilator and/or nitric oxide delivery system
AU2017240366A1
Apparatus and method for filtering liquid particles from inspiratory gas flow of a patient breathing circuit affiliated with a ventilator and/or nitric oxide delivery system
WO2017136340A1
Compensating for disruptions in breathing gas flow measurement
AU2017218391A1
Use and monitoring of inhaled nitric oxide with left ventricular assist devices
CA3000210A1
Device and method for diffusing high concentration no with inhalation therapy gas
CN108136140A
For the device and method for spreading higher concentration NO together with inhalation therapy gas
EP3310407A1
Devices, methods, and systems for priming, separating, and collecting blood components
CA2984105A1
Support for centrifuge tubing
US2016183517A1
Administration and monitoring of nitric oxide in ex vivo fluids
AU2016200623A1
High-purity large-scale preparation of stannsoporfin
CA2965325A1
Method of treating patients with hepatorenal syndrome type 1
